Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Biliary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06431490
What this trial is testing

TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 102
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT02053376
What this trial is testing

Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

Who this might be right for
Metastatic Biliary Tract Carcinoma
Nathan Bahary, MD 43
Testing effectiveness (Phase 2)Study completedNCT00123825
What this trial is testing

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

Who this might be right for
Gallbladder CancerBiliary Tract Cancer
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00266097
What this trial is testing

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 23
Very early researchLooking for participantsNCT06937567
What this trial is testing

CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Who this might be right for
Biliary Tract CancerColorectal CarcinomaGastric Cancer, Metastatic+2 more
Zhejiang University 36
Testing effectiveness (Phase 2)Ended earlyNCT01171755
What this trial is testing

Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 19
Not applicableStudy completedNCT01905384
What this trial is testing

Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction

Who this might be right for
Distal Bile Duct Obstruction
Vanderbilt University Medical Center 6
Testing effectiveness (Phase 2)Study completedNCT00238212
What this trial is testing

S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the Gallbladder+7 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT07641036
What this trial is testing

Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more
Beijing Biotech 30
Not applicableWithdrawnNCT04404647
What this trial is testing

Irreversible Electroporation of Unresectable Liver Tumors

Who this might be right for
Liver MetastasesHepatocellular CarcinomaBile Duct Cancer
Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793253
What this trial is testing

Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer

Who this might be right for
Biliary Tract CancersIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Looking for participantsNCT07392541
What this trial is testing

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
Tongji Hospital 29
Large-scale testing (Phase 3)Study completedNCT00513539
What this trial is testing

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 92
Testing effectiveness (Phase 2)Study completedNCT00059865
What this trial is testing

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 68
Early research (Phase 1)Ended earlyNCT02267707
What this trial is testing

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia

Who this might be right for
Pancreatic NeoplasmsCholestasis
Celgene 1
Next Page